ARTICLE | Emerging Company Profile
Emmecell: magnetic cell therapy for eye diseases
Emmecell is slated to begin Phase I testing in corneal edema patients next year
October 3, 2020 3:24 AM UTC
Emmecell emerged from stealth last week with a clinic-ready cell therapy for corneal edema that could address mild disease and offer a less invasive alternative to corneal transplant surgery in patients with more severe disease.
Corneal edema involves fluid buildup in the cornea that blurs vision and causes pain. Mild cases go untreated and the only option available for more severe cases is a corneal transplant. ...